Dyer’s woad root

Dyer's Woad Root (Isatis tinctoria L.): A Comprehensive Reference

1. Identity: Botanical Classification, Nomenclature, and Common Forms

1.1 Botanical Name and Taxonomy

Isatis tinctoria L., commonly called woad, dyer's woad, dyer's-weed, or glastum, is a flowering plant in the family Brassicaceae (the mustard family) with a documented history of use as a blue dye and medicinal plant. The double use of woad is seen in its name: the term Isatis is linked to its ancient use to treat wounds, while the term tinctoria references its use as a dye. A widely employed synonym — particularly in Chinese pharmacopeial literature — is Isatis indigotica Fort. In the pharmacopoeial monograph, Isatis indigotica was listed as another name for Isatis tinctoria, a record maintained until the current 10th edition of the European Pharmacopoeia. When describing Isatidis radix and Isatidis folium, many researchers following the Chinese pharmacopoeia identify these raw materials as originating from I. indigotica, though some newer works consider them two different species.

1.2 Geographical Origin and Distribution

Woad is native to the steppe and desert zones of the Caucasus, Central Asia to Eastern Siberia and Western Asia, but is now also found in south-eastern and central Europe and western North America. Although native to the grasslands of southeastern Russia, it spread widely across Asia and Europe by cultivation and is considered a noxious weed in most of the western United States.

1.3 Botanical Description

Commonly called woad, dyer's woad, or pastel, it is a short-lived perennial or biennial of the mustard family. It typically grows in the first year as a large-taprooted basal rosette to 12 inches tall, with branched, alternate-leaved flowering spikes rising above the basal rosette in the second year to 2–4 feet tall. Basal leaves are oblong-lanceolate, entire to toothed, and long-petioled. Cauline leaves, which are narrower than basal and gradually reduced upwards, are simple, entire, sagittate, and usually amplexicaul. The flowers are gathered in a racemose inflorescence, with yellow petals and a tetradynamous androecium consisting of six stamens with two filaments shorter than the others.

1.4 Pharmacopoeial Recognition

In 2011, I. tinctoria root was accepted in official European phytotherapy by the introduction of its monograph into the European Pharmacopoeia. The Chinese Pharmacopoeia reports three monographs for I. tinctoria: Băn Lán Gēn (Isatidis radix), Dà Qīng Yè (Isatidis folium), and Qing Dai (Indigo naturalis). The dried roots and leaves — named Banlangen (BLG) and Daqingye (DQY) in Chinese, respectively — are both recorded in the Chinese Pharmacopoeia since 1985.

1.5 Common Forms and Preparations

Dyer's woad root is encountered in commercial and traditional settings in a variety of forms:

• Dried crude root (Isatidis radix / Ban Lan Gen): Băn Lán Gēn is the dried root of I. tinctoria harvested in provinces of China such as Hebei, Jiangsu, and Anhui during the autumn, dried in the sun, and processed into granules (Banlangen Keli).
• Granules and decoctions: BLG has been widely used in Chinese medicine preparations such as Banlangen Granules (BLGG) and Banlangen Tea (BLGT).
• Standardized extracts: Lipophilic (dichloromethane or supercritical CO₂) and hydroalcoholic extracts are the forms most used in modern pharmacological research.
• Topical preparations: Extracts from related Isatis-derived materials, most notably Indigo naturalis (Qing Dai), are formulated as ointments and oils for dermatological use.
• Powder: Currently, I. tinctoria is utilized more often as a medicinal remedy and also as a cosmetic ingredient.

2. Traditional and Historical Use

2.1 Prehistoric and Ancient Use as a Dye

Woad was valued for its rich blue pigment, and archaeological evidence traces its use as a natural dye back to the Neolithic period in France, the Bronze Age in Austria and Germany, the Iron Age in Northern Europe and the British Isles, and the Pharaonic period in Egypt. Woad was an important source of blue dye cultivated throughout Europe, especially in Western and Southern Europe. In medieval times, there were important woad-growing regions in England, Germany, and France.

2.2 European Medicinal Tradition

Its traditional use in western herbal medicine is similar to the Chinese, with the earliest known mention dating to the Hippocratic corpus (5th century BCE), where it is recommended for treating wounds, ulcers, and haemorrhoids. Dioscorides (1st century CE) recorded that the leaves of dyer's woad can be applied to dissolve oedema or tumours, heal bloody wounds, stop bleeding, and cure spreading ulcers, herpes, and rotten ulcers.

From the 12th up to the 17th century, I. tinctoria was widely cultivated in Europe (Germany, France, England, and Italy) and extensively used as an indigo dye and medicinal plant. In the early 17th century, I. tinctoria was intentionally taken from Europe into North America by early colonists as a textile dye crop. In the late 17th century, the decline of the woad industry in Europe was initiated due to the import of indigo blue from Indigofera tinctoria cultivated in Asia, which was easier and more economical to extract. The crop was definitively abandoned in the late 19th century, when synthetic dye production completely replaced natural indigo, and with the decline in its importance as a dye, the plant also fell into oblivion as a medicinal plant.

2.3 Traditional Chinese Medicine (TCM)

Owing to the efficacies of heat-clearing and detoxifying, cooling blood and eliminating ecchymoses, antibiosis and anti-inflammation, the root and leaf have been widely used in combination with other Chinese medicines to treat and prevent a variety of diseases such as influenza, parotitis, epidemic encephalitis B, epidemic myelitis, epidemic cerebrospinal meningitis, acute infectious hepatitis, and sore throat.

Traditionally, it is believed that BLG and DQY have been commonly applied in Eastern countries for centuries to improve symptoms of sore throat, cold, fever, viral hepatitis, and epidemic encephalitis B. In addition, they could be used alone or in combination with other clearing-heat and detoxifying herbs. In TCM theory, they have been utilized as medicines and are listed in the Chinese Pharmacopoeia for their heat-clearing and detoxification properties in Southeast Asia, China, and India for a long history.

As an important ingredient in the so-called Three Drugs and Three Prescriptions, the dried root of Isatis tinctoria has also been playing an active role in fighting against novel coronavirus disease 2019 (COVID-19).

2.4 Ayurvedic and Other Traditions

In both traditional Chinese medicine and Ayurveda, it is used in combination with isatis leaf and other herbs to treat the common cold, sore throat, mumps, respiratory ailments, other febrile diseases, hepatitis, and malignant tumors. I. tinctoria is also widely employed against nervous disorders, including epilepsy, in folk medicine.

3. Key Constituents and Active Compounds

3.1 Phytochemical Overview

More than 300 components have been isolated from the root of Isatis indigotica, including alkaloids, sulfur-containing compounds, phenylpropanoids, amino acids, nucleosides, organic acids and esters, flavonoids, quinones, terpenes, sterols, saccharides, aromatics, peptides, alcohols, aldehydes and ketones, nitriles, and sphingolipids. The dried root is one of the most popular traditional Chinese medicines with well-recognized prevention and treatment effects against viral infections.

3.2 Indole Alkaloids

More than 100 alkaloids have been isolated from I. tinctoria, including indole alkaloids, quinazolone alkaloids, quinoline alkaloids, and others.

• Tryptanthrin — The cyclooxygenase-2 inhibitory principle was identified with the aid of HPLC-based activity profiling as the alkaloid tryptanthrin. In cell-based assays, tryptanthrin strongly inhibited eicosanoid synthesis catalyzed by cyclooxygenase-2 and 5-lipoxygenase. Tryptanthrin has strong inhibitory effects on dermatophytes including Trichophyton mentagrophytes, Trichophyton rubrum, Trichophyton tonsurans, and Microsporum canis. The roots have broad-spectrum antibacterial activity, in which tryptanthrin is the main antibacterial active ingredient.
• Indirubin — Several studies demonstrated that indirubin is a potent inhibitor of cyclin-dependent kinase 5 (CDK5/P25) and glycogen synthase kinase-3-β (GSK-3-β), as well as interferon-γ and interleukin-6. Indirubin inhibits cyclin-dependent kinases and prevents proliferation by arresting cells in the G2/M phase.
• Indigo (Indigotin) — A blue pigment, co-produced with indirubin from indoxyl precursors in the plant. After cleavage of the O-glycosidic linkage, indoxyl is released and gives rise to indigo through oxidation; the condensation of indoxyl with isatin produces the red indigoid pigment indirubin.
• Indolin-2-one (Indolinone) — One of the active compounds isolated from I. tinctoria leaves responsible for anti-allergic properties is the alkaloid indolin-2-one. It has been demonstrated that indolinone inhibits compound 48/80-induced histamine release from rat peritoneal mast cells, and was found to block IgE-mediated degranulation of sensitized mast cells at nM concentrations without directly interfering with signalling upstream of the histamine-containing granules.
• Isatisine A and related compounds — A compound derived from isatisine A showed moderate anti-HIV-1 activity.
• Epigoitrin — Epigoitrin has been used as a therapeutic marker for antivirals in the Chinese Pharmacopoeia.

3.3 Glucosinolates

The anti-influenza virus activity of epiprogoitrin, progoitrin, epigoitrin, and goitrin — the Isatidis radix-derived glucosinolate isomers and their breakdown products — has been evaluated. Epigoitrin was found in the roots of Isatis tinctoria. These glucosinolate isomers and their breakdown products all exhibited dose-dependent inhibition of influenza A virus (H1N1) without toxicity. The antiviral potency was in the order progoitrin > goitrin > epigoitrin > epiprogoitrin. The attachment of these constituents to the viral envelope was proposed as the mechanism of antiviral action, without disturbing viral adsorption or budding.

3.4 Polysaccharides

The polysaccharide compounds contained in Isatidis radix also have anti-influenza virus activity, as demonstrated by in vitro investigations. A polysaccharide isolated from Isatidis radix inhibited the attachment of the influenza virus to red blood cells and promoted the generation of anti-influenza viral IgG antibodies. Polysaccharides have also been reported to exert immunomodulatory activity, with research noting two-way immunoregulation in experimental models.

3.5 Phenolic Compounds and Flavonoids

Flavonoid constituents identified in I. tinctoria hairy root cultures include rutin, neohesperidin, buddleoside, liquiritigenin, quercetin, isorhamnetin, kaempferol, and isoliquiritigenin. The antioxidant capacities of these flavonoid-rich extracts are of broad interest in food, cosmetic, and pharmaceutical fields.

3.6 Other Constituents

The root contains compounds including indigo, indigotin, indirubin, epigoitrin, adenosine, and L-arginine. Nucleosides, including adenosine, have been shown to be bioactive compounds associated with immunomodulatory, antiviral, and anti-inflammatory effects. Additionally, various lipophilic constituents belonging to different chemical classes play important roles in the anti-inflammatory activity of I. tinctoria extracts, including the alkaloids tryptanthrin, indirubin, and indolinone, and fatty acids such as linolenic acid.

4. Mechanisms of Action

4.1 Anti-inflammatory Mechanisms

In a broad-based screening, a dichloromethane extract from the leaves displayed significant activities on several clinically relevant targets of inflammation. The cyclooxygenase-2 inhibitory principle was identified as the alkaloid tryptanthrin. In cell-based assays, tryptanthrin strongly inhibited eicosanoid synthesis catalyzed by cyclooxygenase-2 and 5-lipoxygenase.

Other alkaloids isolated from isatis inhibit leukocyte function and attenuate production of mediators related to inflammatory responses. Root extracts have been reported to inhibit the activity of iNOS and COX-2 by suppressing expression of the MAPK/NF-κB pathway.

4.2 Antiviral Mechanisms

Epigoitrin significantly decreased the susceptibility of restrained mice to influenza virus, evidenced by lowered mortality, attenuated inflammation, and decreased viral replication in lungs. Further results revealed that epigoitrin reduced the protein expression of mitofusin-2 (MFN2), which elevated mitochondria antiviral signaling (MAVS) protein expression and subsequently increased the production of IFN-β and IFITM3, thereby helping to fight viral infections.

Methanol extract, indigo, and indirubin showed inhibitory effects (concentration-dependent) on JEV replication in vitro. Time-of-addition experiments demonstrated potent antiviral effect by pretreatment or simultaneous treatment, but not posttreatment after viral entry. Antiviral action showed correlation with blocking virus attachment and exhibited potent virucidal activity.

4.3 Antitumor and Antiproliferative Mechanisms

Indirubin is a potent inhibitor of cyclin-dependent kinase 5 (CDK5/P25) and glycogen synthase kinase-3-β (GSK-3-β), as well as interferon-γ and interleukin-6. Indirubin inhibits cyclin-dependent kinases and prevents proliferation by arresting cells in the G2/M phase.

4.4 CYP450 Interactions

Lab studies suggest that indirubin, a component of the isatis plant, may affect how CYP450 3A4 substrate drugs are metabolized, though the clinical relevance has yet to be determined.

5. Scientific Evidence by Area of Use

5.1 Antiviral Activity

Evidence level: Preclinical (in vitro and animal); clinical guidelines (TCM, weak recommendation)

Isatis indigotica is traditionally used in clinical treatment of viral diseases like influenza, hepatitis, and encephalitis. Accumulated experimental evidence indicates it and related components as associated with antiviral activity against influenza A, SARS-coronavirus, foot-and-mouth disease, rabies, and HIV-1, among others.

Indirubin had strong protective ability in a mouse model with lethal JEV challenge. Indirubin had potent in vivo protection against intracerebral JEV challenge at lethal dose, more than indigo, ethyl acetate extract, or methanol extract.

Chinese clinical practice guidelines weakly recommend Banlangen granules to treat mild influenza. In vitro assays have identified specific compounds in isatis root with potential anti-SARS and anti-influenza activity, as well as cytotoxic activity against human liver cancer and leukemia cell lines. Robust randomized controlled human clinical trials directly using isolated root extracts at defined doses are limited; the existing evidence base is primarily preclinical.

5.2 Anti-inflammatory Activity

Evidence level: Preclinical (in vitro and animal); no definitive human trials for isolated root extracts

Dichloromethane and carbon dioxide extracts showed in vivo anti-inflammatory activity in both topical and oral application in animal models. With the aid of electrospray ionization liquid chromatography-mass spectrometry coupled skin microdialysis, tryptanthrin was found to penetrate the skin. It has been shown that the tryptanthrin contained in the extracts penetrates to a greater extent than that of pure solutions; in the extract, the alkaloid remains in molecular dispersion, while in pure solution it tends to crystallize on the surface of the skin.

5.3 Antitumor/Oncological Applications

Evidence level: Preliminary; mainly in vitro and one older clinical report for indirubin in leukemia

Lab studies suggest that indirubin, an active compound in isatis, stops cell duplication and therefore may be useful in cancer treatment, but studies in humans are lacking.

Indirubin, isolated from indigo naturalis (which includes I. tinctoria as a source plant), was used as a new agent to treat leukemia in China in the 1970s. In reported Chinese clinical experience, indirubin was evaluated in patients with chronic myelocytic and chronic granulocytic leukemia; one report noted that a substantial proportion of patients showed complete or partial remission, with toxicity described as relatively mild, though this was not a rigorous, blinded, modern randomized controlled trial.

The formula Danggui Longhui Wan — which contains isatis-derived indirubin — is used in China to treat chronic myelocytic leukemia.

5.4 Antimicrobial Activity

Evidence level: Preclinical (in vitro); no adequate clinical trials

The aqueous, ethanol, and n-butanol extracts of the leaves have antibacterial effects on Staphylococcus aureus and Escherichia coli. The leaf decoction showed an antibacterial effect in vitro on Staphylococcus aureus, Staphylococcus albus, Streptococcus A and Streptococcus B by use of disk diffusion test. These findings are exclusively in vitro, and no adequately powered human clinical trials have established efficacy for bacterial infections in humans.

5.5 Dermatological Use (Psoriasis and Atopic Dermatitis)

Evidence level: Limited clinical evidence (for indigo naturalis / Qing Dai preparations); preliminary for isolated root extract

Indigo naturalis, derived in part from Isatis tinctoria, has been traditionally used in treatment of hemoptysis, epistaxis, chest pain, aphtha, and infantile convulsion. Clinical trials have shown that the curative effect of indigo naturalis for psoriasis and ulcerative colitis is remarkable.

Some research suggests that applying a specific product containing indigo naturalis oil extract (Lindioil) to the fingernails and the skin beneath the edge of the nail twice daily for 24 weeks improves psoriasis by 50% to 80%. It is important to note that these clinical findings pertain to topical preparations of indigo naturalis (Qing Dai) — a mixture derived from multiple Isatis-related plants — rather than isolated dyer's woad root extract specifically.

5.6 Immunomodulatory Activity

Evidence level: Preclinical

Indigo and indirubin have been reported to have anti-tumor, anti-inflammatory, and immune-enhancing effects of polysaccharides. A polysaccharide isolated from Isatidis radix inhibited the attachment of the influenza virus to red blood cells and promoted the generation of anti-influenza viral IgG antibodies. Immunomodulatory effects of polysaccharides from the root have been reported in animal models including cyclophosphamide-immunosuppressed rats, but human data are lacking.

5.7 Neurological and Neuroprotective Effects

Evidence level: Very preliminary; animal/in vitro only

Extracts obtained from Isatis tinctoria possess the ability to inhibit the formation/activity of nitric oxide and display anti-inflammatory, antioxidant, and neuroprotective properties. Methanol extract of Isatis species' leaves was reported to exert a significant protective effect against seizures (p < 0.01) in mice, similar to the standard drug diazepam. No human clinical studies have confirmed these effects for the root specifically.

6. Body Systems and Health Areas Associated with Dyer's Woad Root

• Immune System: Immunomodulatory effects via polysaccharides and alkaloids; promotion of antiviral antibody production.
• Respiratory System: Widely used in combination with other Chinese medicines to treat influenza, parotitis, epidemic encephalitis B, epidemic myelitis, epidemic cerebrospinal meningitis, acute infectious hepatitis, and sore throat.
• Hepatic System: Traditional use for viral hepatitis, with some preliminary clinical observation reports in TCM practice.
• Integumentary System (Skin): Anti-inflammatory and anti-allergic properties relevant to dermatitis and psoriasis; tryptanthrin's skin penetration supports topical use.
• Oncological: Primarily indirubin-driven antiproliferative activity at the cell biology level; some historical clinical application in leukemia.
• Neurological: Folk use against epilepsy and nervous disorders; preliminary animal evidence of anticonvulsant and neuroprotective effects.
• Cardiovascular/Hematological: Although it may be effective against ulcerative colitis, its use has been associated with a serious condition called pulmonary arterial hypertension.

7. Dosage Forms and Dosages Reported in Studies

Dosage information derives exclusively from TCM practice documentation and experimental literature. No standardized dose has been established by a Western regulatory authority for dyer's woad root as a dietary supplement.

• Traditional TCM dried powder: Two to three grams per day (as reported in TCM clinical practice sources).
• Concentrated dried decoction extract: One to four grams per day (as reported in TCM clinical practice sources).
• Animal/preclinical studies (leaf extract, intraperitoneal): In mouse studies, extract was administered intraperitoneally at doses of 50 mg/kg, 100 mg/kg, or 500 mg/kg body weight.
• Topical (indigo naturalis oil extract / Lindioil): When applied to the skin, isatis is possibly safe when used appropriately, short-term. A specific product containing an isatis leaf extract called indigo naturalis in olive oil (Lindioil) has been used safely for 24 weeks.
• Anti-helminthic animal study (crude extract): It was orally administered to lambs naturally infected with gastrointestinal nematodes in doses of 125, 250, and 500 mg/kg and induced a moderate and dose-dependent decrease in faecal egg count compared to the positive control albendazole.

A screening of 67 woad samples of different geographic origin revealed up to 30-fold differences in tryptanthrin content in leaves, underscoring the difficulty of standardizing dosage across preparations.

8. Safety Considerations and Drug Interactions

8.1 Adverse Events and Toxicity

Although isatis may be effective against certain conditions such as ulcerative colitis, its use has been associated with a serious condition called pulmonary arterial hypertension. Therefore it should not be used outside of clinical trials when referring specifically to oral indigo naturalis preparations. This safety signal arises primarily from indigo naturalis/Qing Dai preparations and has been documented in the medical literature; attribution to the root alone specifically is not yet fully established.

One of the most common side effects experienced by users of Banlangen (the root preparation) is gastrointestinal discomfort, which can manifest as nausea, vomiting, diarrhea, or abdominal pain. These symptoms are generally mild and temporary but can be distressing for some individuals, especially those with sensitive digestive systems.

There have been reports of liver and kidney toxicity associated with prolonged use. Symptoms of liver toxicity include jaundice, dark urine, fatigue, and abdominal pain. Kidney toxicity may present as reduced urine output, swelling of the legs and ankles, and elevated blood pressure.

8.2 Allergic Reactions

Isatis contains chemicals that are similar to the chemicals in aspirin. Isatis might trigger an asthma attack or an allergic reaction in people who are allergic to aspirin.

8.3 Duration of Use

TCM practice recognizes dyer's woad root as a potent, cold-natured herb not suited to extended use. Long-term use has been associated with disruption of beneficial intestinal microbiota and, in TCM terms, weakening of digestive function. The herb is traditionally employed for acute, short-duration presentations rather than chronic supplementation.

8.4 Drug Interactions

Lab studies suggest that indirubin, a component of the isatis plant, may affect how CYP450 3A4 substrate drugs are metabolized, though clinical relevance has yet to be determined.

It is important to note that Banlangen may interact with certain medications: it may enhance the effects of anticoagulants (blood thinners), leading to an increased risk of bleeding, and may interfere with immunosuppressive drugs, potentially reducing their effectiveness. These interaction reports are based on theoretical pharmacological grounds and limited case data, not rigorous pharmacokinetic interaction studies.

8.5 Populations Requiring Caution

The biological properties of the raw material have been known from Traditional Chinese Medicine, which classifies it as a potent herb. TCM sources caution against use in patients with severe constitutional weakness and restrict or reduce doses in children. Pregnancy and lactation safety has not been established in any rigorous study.

8.6 Adulteration and Quality Control

Implementation of a track-and-trace system is strongly recommended to prevent and deter incorrect supply chain practices that lead to substitution or adulteration in commercially supplied Isatidis radix and folium products. Misidentification and substitution with Strobilanthes species has been documented in quality assessments of commercial materials.

9. Summary of Evidence Strength

The overall evidence base for dyer's woad root as a dietary supplement or phytomedicine remains predominantly preclinical. Modern in vitro and in vivo scientific studies have proven anti-inflammatory, anti-tumour, antimicrobial, antiviral, analgesic, and antioxidant activities. However, the vast majority of these findings come from cell culture and animal models. The most substantiated human-level evidence is for indigo naturalis preparations (which include but are not limited to I. tinctoria) in psoriasis and — with critical safety caveats — ulcerative colitis. Chinese clinical practice guidelines weakly recommend Banlangen granules to treat mild influenza, but this represents expert consensus rather than pooled high-quality RCT data. Adequately powered, placebo-controlled, double-blind human clinical trials using characterised, isolated dyer's woad root extract are lacking for all proposed indications as of the time of writing.

References

• Speranza J. et al. — Isatis tinctoria L. (Woad): A Review of Its Botany, Ethnobotanical Uses, Phytochemistry, Biological Activities, and Biotechnological Studies. PMC/Plants (2020)
• Chen Q. et al. — Isatis indigotica: a review of phytochemistry, pharmacological activities and clinical applications. PMC/J Pharm Pharmacol (2021)
• Ye M. et al. — Antiviral Activity of Isatis indigotica Extract and Its Derived Indirubin against Japanese Encephalitis Virus. PMC/Evidence-Based Complementary and Alternative Medicine (2012)
• Nie L.X. et al. — Microscopic Mass Spectrometry Imaging Reveals the Distribution of Phytochemicals in the Dried Root of Isatis tinctoria. PMC/Frontiers in Pharmacology (2021)
• Nicosia N. et al. — Hydroalcoholic Leaf Extract of Isatis tinctoria L. via Antioxidative and Anti-Inflammatory Effects Reduces Stress-Induced Behavioral and Cellular Disorders in Mice. PMC/Oxidative Medicine and Cellular Longevity (2022)
• Liu Y. et al. — A Comprehensive Review of the Chemistry, Pharmacokinetics, Pharmacology, Clinical Applications, Adverse Events, and Quality Control of Indigo Naturalis. PMC/Frontiers in Pharmacology (2021)
• Xu L. et al. — Alkaloids with Nitric Oxide Inhibitory Activities from the Roots of Isatis tinctoria. PMC/Molecules (2019)
• Liu Y. et al. — Epigoitrin, an Alkaloid From Isatis indigotica, Reduces H1N1 Infection in Stress-Induced Susceptible Model in vivo and in vitro. PMC/Frontiers in Microbiology (2019)
• Zhu Y. et al. — In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L. PMC/Frontiers in Pharmacology (2021)
• Hamburger M. — Isatis tinctoria – From the Rediscovery of an Ancient Medicinal Plant Towards a Novel Anti-Inflammatory Phytopharmaceutical. Phytochemistry Reviews (2002)
• Luo Y. et al. — Antiviral Activity of Isatidis Radix Derived Glucosinolate Isomers and Their Breakdown Products against Influenza A in vitro/ovo and Mechanism of Action. Journal of Ethnopharmacology (2020)
• Isatis tinctoria — ScienceDirect Topics Overview
• Isatis Root — Memorial Sloan Kettering Cancer Center Integrative Medicine Herb Profile
• Isatis Leaf — Memorial Sloan Kettering Cancer Center Integrative Medicine Herb Profile
• Szopa A. et al. — Establishment of Hairy Root Cultures by Agrobacterium Rhizogenes Mediated Transformation of Isatis tinctoria L. for the Efficient Production of Flavonoids and Evaluation of Antioxidant Activities. PMC (2015)
• Quality assessment of medicinal material Daqingye and Banlangen from Isatis tinctoria — PMC (2025)
• Inhibitory effect of Isatis tinctoria L. water extract on DNCB-induced atopic dermatitis in BALB/c mice and HaCaT cells — PMC (2022)